PSP Education Materials in Egypt: Control Approval, Versions and Withdrawal

Quick answer
Link each approved material to its final language-specific file and delivery permissions. Confirm the applicable review route, prepare educators and track withdrawal of outdated copies.
Before a patient educator uses a leaflet, presentation or message in an Egyptian patient support program, the program team needs to know which version is authorized, who may use it and what to do when it changes. A polished document is not enough. The operational task is to connect content approval with the material actually available during a session, including printed copies, translated files and attachments stored on staff devices.
This guide helps pharma and PSP operations teams design that connection. It does not approve any medicine-specific material or determine a program's regulatory classification. Those decisions belong to the sponsor's responsible medical, regulatory and pharmacovigilance functions. The framework below concerns content ownership, release and withdrawal. It provides no dosing instructions, treatment recommendations or assurance that a particular material has regulatory clearance.
Classify the material before choosing its route
Start by recording the material's purpose, audience and proposed channel. Distinguish general service information from medicine-specific education, promotional material and additional risk-minimization material. A file name containing the word education does not establish which requirements apply. Ask the sponsor's designated experts to determine the appropriate review route and record their decision before design, translation or distribution work advances too far.
The Egyptian Drug Authority's 2026 GVP guideline addresses educational materials used for additional risk minimization. It specifies non-promotional content, approval before distribution and Arabic preparation and submission for materials intended for patients in that context. These provisions should not be generalized into a claim that every administrative PSP document follows the same route. Confirm applicability and current requirements with the sponsor's responsible specialists.
Keep that classification decision with the source record. Staff preparing a distribution list should not have to infer whether a file is approved from its appearance or from an email saying the artwork looks good. Identify the final approval evidence, any restrictions and the person authorized to release the material for use. An unfinished review is a reason to hold that material, not to improvise an alternative explanation for patients.
Build a material register people can maintain
Use a register that records the material identifier, title, language, format, audience, owner and version. Add the source document, approval reference, effective date and review trigger where applicable. Link to the controlled master rather than attaching separate working copies to every row. The register should answer which material is current and where it can be obtained without becoming a second uncontrolled content repository.
Give the material a stable identifier across revisions while making each version distinguishable. Decide how English and Arabic versions are related and what happens when one language changes. A translated file should have its own review status. Approval of the English source alone should not be treated as proof that the Arabic wording, layout or intended use has been checked by the appropriate reviewer.
Record who can edit, approve, release and withdraw. These responsibilities may sit with different people and organizations. A service provider can distribute the agreed version while the sponsor retains approval responsibility. Document that boundary in the working arrangement, including who answers questions when the supplied content and the approved record appear inconsistent. Do not resolve an ambiguous instruction through an unrecorded local edit.
Review the Arabic version as a patient-facing document
Arabic review needs more than checking that every English sentence appears somewhere in the translation. Ask the authorized reviewer to examine meaning, terminology, reading order, numbers, units and instructions as they will appear to the intended audience. Review the final rendered file, including captions and callouts. A correct translation can still become confusing when the layout separates a qualifying statement from the instruction it qualifies.
Agree a small terminology list for the program and keep it with the content record. It should support consistency without forcing technical language into every patient conversation. Educators can use approved explanations within their role; they should know which questions require referral rather than an improvised answer. Record language feedback as a proposed revision for review, not as permission for staff to rewrite distributed materials individually.
Consider access needs during planning. Ask whether the intended participants can use the proposed print size, digital format and delivery channel, and whether an approved alternative format is needed. Do not assume every patient can open a file or scan a code. The choice of format should make the approved information usable while preserving its content and review status, not create a separate informal version with different instructions.
Connect release with educator readiness
Release should include the final file, its effective date, permitted audience and channels, and a concise explanation of any change relevant to delivery. Identify the person who confirms receipt by the delivery team. Where the change affects how educators conduct a session, arrange the appropriate briefing before use. Sending a link alone does not establish that staff understand what changed or which older material must be removed.
Educators need a defined boundary for questions beyond the material. Specify the clinical referral route, the sponsor's safety-reporting contact and the operational contact for content errors. These routes serve different purposes. A suspected adverse event must follow the agreed safety procedure; a request to change treatment belongs with the treating professional. Neither should wait for the next routine artwork review meeting.
Hospitalia's patient-education service describes work with sponsor-approved materials, defined educator roles, accessible sessions and clinical and safety referral pathways. That is a service scope to discuss, not evidence that Hospitalia can approve a sponsor's content. Agree the format, staffing, locations, approval responsibilities and delivery boundaries in the proposal, including how the team will access the controlled materials during actual sessions.
Withdraw the old version deliberately
Map where each released material is used: the central repository, printed stock, staff-held copies, scheduled messages and any authorized external distribution points. Assign an owner for updating each location. A replacement on the shared drive does not automatically update an attachment already saved elsewhere. Keep the withdrawal instructions specific enough that staff can identify the affected version and confirm the action taken.
When a change has potential safety significance, the sponsor's responsible experts should decide whether additional communication or other action is needed. Do not assume a routine file replacement resolves the issue. Record the decision and follow the relevant approved process. Operational staff can track completion, but should not independently judge the clinical significance of a content error or decide which patient instructions remain safe to use.
Retain the historical record according to the applicable approved retention arrangements. Mark withdrawn versions clearly and restrict their use to legitimate recordkeeping. A historical copy may be needed to understand what was available at an earlier date; it should not appear beside current materials without a visible status. Decide who can retrieve it and how the team prevents accidental redistribution.
Learn from delivery without claiming outcomes prematurely
Use session feedback to identify unclear wording, recurring unanswered questions and access problems. Capture the material version associated with the feedback where appropriate. Separate a proposed content improvement from a clinical concern and from a safety report. Each needs the correct owner. Avoid collecting identifiable patient stories in a general content-improvement spreadsheet when aggregated themes are sufficient.
Review operational measures such as whether staff used the current version, whether required briefings were completed and whether withdrawal actions were closed. Define the period and evidence source. Material distribution and session attendance do not demonstrate understanding, adherence or improved health outcomes. Any evaluation of those outcomes requires an appropriate design, permitted data and responsible professional oversight rather than inference from activity counts.
A release decision the team can explain
- Confirm the material's purpose, audience and applicable review route with the sponsor's responsible specialists.
- Match the final language-specific file to its approval evidence, version and permitted distribution channels.
- Confirm educator access, relevant briefing and routes for clinical questions, safety information and content errors.
- Identify older copies, assign withdrawal actions and record whether additional communication is required by the responsible experts.
- Preserve the decision history and use delivery feedback to propose reviewed changes rather than uncontrolled local edits.
The useful endpoint is a release record that connects authorization, the final file and delivery readiness. Pharma teams can discuss their patient-education workflow with Hospitalia using that record as a starting point. Confirm the service scope and content responsibilities before launch. Clear version control supports accountable delivery while leaving medical, regulatory and pharmacovigilance decisions with the professionals responsible for them.
Suitability, scope, availability and fees are confirmed when discussing your request.
Contact the Hospitalia team
